Posaconazole Tablet, Delayed Release
Product Images NDC 72162-2243

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 72162-2243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622243)

Label (Lbl721622243)
Posaconazole Delayed-Release Tablets 100 mg label with NDC 72162-2243-6 by Bryant Ranch Prepack. The label indicates a package size of 60 tablets, prescription only. It includes storage instructions, a barcode, and manufacturer i3 Pharmaceuticals, LLC. The label highlights that Noxafil oral suspension and delayed-release tablets are not interchangeable.*
FDA Label Image

Structure.jpg (Structure.jpg)

Structure.jpg (Structure.jpg)
Chemical structure of Posaconazole, showing its detailed molecular arrangement with various aromatic rings, heterocycles, and functional groups including fluorine atoms and hydroxyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.